CHANGES IN ANTIOXIDANT ENZYMES ACTIVITIES, AGGREGABILITY AND MALONYLDIALDEHYDE CONCENTRATION IN BLOOD-PLATELETS FROM PATIENTS WITH CORONARYHEART-DISEASE
A. Buczynski et al., CHANGES IN ANTIOXIDANT ENZYMES ACTIVITIES, AGGREGABILITY AND MALONYLDIALDEHYDE CONCENTRATION IN BLOOD-PLATELETS FROM PATIENTS WITH CORONARYHEART-DISEASE, Atherosclerosis, 100(2), 1993, pp. 223-228
In 41 patients with coronary heart disease (CHD) the concentrations of
total blood platelet malonyldialdehyde (MDA: 2.11 +/- 0.25 nmol/109 p
latelets) and MDA corresponding to thromboxane A2 (TXA2 0.84 +/- 0.13
nmol/109 platelets) were increased in comparison with values in blood
platelets of healthy subjects (1.19 +/- 0.09 and 0.71 +/- 0.05 nmol/10
(9) platelets), respectively. The increased aggregability with ADP and
thrombin of patient platelets was also observed. In relation to the b
lood platelets of healthy subjects, the antioxidant enzymes activities
of patient blood platelets were significantly (P < 0.001) decreased.
Platelet glutathione peroxidase (GSH-Px) activity of the patients (11.
3 +/- 0.85 U/g protein) was significantly lower than controls (18.3 +/
- 1.12 U/g protein). In patients with CHD the activities of the other
antioxidative platelet enzymes: catalase (Cat, 7.37 +/- 1.38 U/g prote
in) and superoxide dismutase (SOD, 1529.4 +/- 167 U/g protein) were al
so significantly decreased in comparison with values for healthy subje
cts (Cat: 9.06 +/- 1.30 U/g protein and SOD: 1987 +/- 230 U/g protein,
respectively). It is suggested that antioxidative defense in blood pl
atelets may affect the haemostatic processes and lipid peroxidation in
patients with CHD.